![]() |
市場調查報告書
商品編碼
1787924
多劑量包裝系統市場預測至 2032 年:按產品、材料、藥品類型、分銷管道、技術、最終用戶和地區進行的全球分析Multi-Dose Packaging System Market Forecasts to 2032 - Global Analysis By Product (Blister Packs, Pouches, Bottles, Sachets, Vials, Jars, Tubes and Other Products), Material, Drug Type, Distribution Channel, Technology, End User and By Geography |
根據 Stratistics MRC 的數據,全球多劑量包裝系統市場預計在 2025 年將達到 37 億美元,到 2032 年將達到 65 億美元,預測期內的複合年成長率為 8.1%。
多劑量包裝系統是一種藥品包裝技術,旨在將多劑量藥物裝入單一容器中。此系統常用於提高服藥依從性,尤其是在慢性病患者以及醫院和養老院等場所。這些方法通常按日期和時間安排劑量,從而減少漏服或錯誤用藥的可能性。多劑量包裝有瓶裝、泡殼包裝、袋裝和其他多種包裝形式,簡化了監測和配藥流程。此外,多劑量包裝還能減少藥物管理的浪費和錯誤,同時提高安全性、便利性和效率。
服藥依從性和便利性的需求不斷增加
有序且標籤清晰的包裝對患者,尤其是老年人和長期患病患者,大有裨益。這些方法能夠確保準確及時地用藥,從而減少用藥錯誤。為了提高病患的依從性,看護者和醫護人員更傾向於使用多劑量包裝。隨著藥房服務品質和安全性的提高,這些解決方案正被擴大採用。整體而言,市場擴張的驅動力是對藥物管理準確性和效率的需求。
初期投資和營運成本高
中小型藥局難以承擔安裝自動化包裝設備所需的龐大成本。維護和員工培訓進一步增加了營運成本。許多醫護人員由於成本高而不願放棄傳統的包裝方法。因此,市場滲透率仍然很低,尤其是在低度開發國家。總體而言,經濟障礙阻礙了這些尖端解決方案的廣泛應用。
與智慧技術和數位健康平台的整合
這些技術能夠實現自動提醒和即時追蹤,從而減少漏服或誤服的幾率。負責人可以透過智慧包裝解決方案取得用藥數據,從而實現更有效的監測和個人化治療方案的調整。數位化連接進一步提升了供應鏈效率和庫存管理。遠端醫療的日益普及進一步增加了遠端醫療的需求。這些發展改善了患者的治療效果,並實現了藥品配送方式的現代化。
嚴格的監管標準和包裝廢棄物問題
由於公司需要遵守嚴格的標籤、材料安全和劑量準確性規定,產品開發可能會被推遲。監管延遲也可能影響創新包裝形式的及時推出。此外,對包裝廢棄物的日益擔憂迫使公司投資永續材料,從而提高了製造成本。現有的多劑量包裝設計在許多地方對回收和處置法規構成挑戰。所有這些因素共同降低了盈利,並阻礙了新的競爭。
COVID-19的影響
新冠疫情 (COVID-19) 大流行顯著影響了多劑量包裝系統市場,增加了對安全高效藥物分配的需求。醫療保健提供者尋求能夠最大程度減少人際接觸並降低污染風險的包裝解決方案,從而推動了醫院和藥房對多劑量系統的採用。供應鏈中斷和原料短缺最初導致生產延遲,但對安全有序的藥物管理的迫切需求刺激了對技術創新和自動化的投資。疫情也凸顯了病患服藥順從性和安全性的重要性,進一步增強了該市場在全球醫療保健體系中的重要性。
預計預測期內瓶裝飲料市場規模最大
由於瓶裝產品在醫藥和醫療保健領域的廣泛應用,預計在預測期內將佔據最大的市場佔有率。瓶裝產品具有精準計量、可重複密封和防污染等特點,是多種用途的理想選擇。其與各種液體和固體製劑的兼容性正推動市場採用。對易於使用且經濟高效的包裝解決方案的需求日益成長,推動了瓶裝產品的偏好。此外,瓶裝設計和永續材料的進步也支持了市場佔有率的擴大。
預計在預測期內,養老院部門的複合年成長率最高。
由於老年人口不斷成長,需要持續的藥物管理,預計養老院市場將在預測期內呈現最高成長率。在這些機構中,藥物管理的安全性和準確性至關重要,而多劑量包裝可以減少用藥錯誤,從而實現這一點。預包裝劑量可以節省時間並簡化配藥流程,從而提高員工效率。隨著監管機構越來越重視護理機構的用藥依從性,對合規包裝的需求也不斷成長。因此,長期照護機構正在推動多劑量包裝系統應用的持續成長。
在預測期內,由於老齡人口成長、慢性病盛行率上升以及醫療基礎設施不斷擴張,亞太地區預計將佔據最大的市場佔有率。中國、日本和印度等國家正在投資先進的醫藥包裝技術,以提高病患依從性並減少用藥錯誤。隨著智慧藥物管理意識的不斷增強,以及快速的都市化和數位化醫療的普及,進一步推動了需求成長。本地企業正在積極創新,推出經濟高效且永續的包裝解決方案,以滿足醫院和居家照護環境日益成長的需求。
預計北美在預測期內的複合年成長率最高,這得益於嚴格的監管標準、先進的製藥實踐以及配藥自動化的大力推廣。美國和加拿大正致力於透過創新的泡殼包裝和支援RFID技術的包裝來最大限度地減少服藥不遵從的情況。主要市場參與者的加入以及長期照護機構、療養院和門診病人服務日益成長的需求正在推動市場擴張。與電子健康記錄(EHR) 和數位處方平台的整合正變得越來越普遍,這使得多劑量包裝對於提高業務效率和患者預後至關重要。
According to Stratistics MRC, the Global Multi-Dose Packaging System Market is accounted for $3.7 billion in 2025 and is expected to reach $6.5 billion by 2032 growing at a CAGR of 8.1% during the forecast period. A pharmaceutical packaging technique called a multi-dose packaging system is made to include several doses of medication in one container. It is frequently used to increase drug adherence, especially for patients with chronic diseases and in environments like hospitals and assisted living facilities. These methods frequently arrange dosages according to date and time, which lowers the possibility of missing or giving the wrong dosage. Available in bottles, blister packs, or pouches, they simplify monitoring and dispensing. Additionally, multi-dose packaging reduces waste and mistakes in the administration and management of medications while improving safety, convenience, and efficiency.
Rising demand for medication adherence and convenience
Well-organised and labelled packaging is beneficial to patients, particularly the elderly and those with long-term illnesses. By guaranteeing precise and timely dosage, these methods lower pharmaceutical mistakes. For better patient compliance, carers and medical professionals favour multi-dose packs. These solutions are being adopted by pharmacies more frequently in an effort to improve service quality and safety. In general, market expansion is driven by the requirement for accuracy and efficiency in drug administration.
High initial investment and operational costs
Small and mid-sized pharmacies may find it difficult to afford the significant expenditure needed to set up automated packaging equipment. Operational costs are further increased by maintenance and employee training. Many healthcare practitioners are discouraged from abandoning traditional packing methods because to the hefty expenses. Consequently, there is still little market penetration, particularly in underdeveloped nations. Overall, financial obstacles prevent these cutting-edge solutions from being widely adopted.
Integration with smart technologies and digital health platforms
The chance of missing or giving the wrong dose is decreased by these technologies, which allow for automated reminders and real-time tracking. Healthcare practitioners can receive usage data via smart packaging solutions, enabling more effective monitoring and individualised treatment modifications. The efficiency of the supply chain and inventory management are further enhanced by digital connectivity. The need for intelligent packaging that supports remote care is further increased by the expanding use of telemedicine. All things considered, these developments enhance patient outcomes and modernise medication distribution methods.
Strict regulatory standards and packaging waste concerns
Product development may be slowed down by the need for businesses to adhere to strict labelling, material safety, and dosage precision regulations. The timely introduction of innovative packaging formats may also be impacted by regulatory delays. Furthermore, companies are being forced to invest in sustainable materials due to increased worries about packaging waste, which raises production costs. Existing multi-dose packaging designs are challenged by recycling and disposal regulations in many places. All of these elements work together to lower profitability and deter new competitors.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the Multi-Dose Packaging System Market by increasing demand for secure and efficient medication dispensing. Healthcare providers sought packaging solutions that minimized human contact and reduced the risk of contamination, driving the adoption of multi-dose systems in hospitals and pharmacies. Supply chain disruptions and raw material shortages initially slowed production, but the urgent need for safe, organized medication delivery fuelled innovation and investments in automation. The pandemic also emphasized the importance of patient adherence and safety, further strengthening the market's relevance in global healthcare systems.
The bottles segment is expected to be the largest during the forecast period
The bottles segment is expected to account for the largest market share during the forecast period, due to its widespread use in pharmaceuticals and healthcare. Bottles offer precise dosing, resealability, and protection from contamination, making them ideal for multi-use applications. Their compatibility with various liquid and solid formulations enhances market adoption. Growing demand for user-friendly and cost-effective packaging solutions boosts their preference. Additionally, advancements in bottle design and sustainable materials support their increasing market share.
The long-term care facilities segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the long-term care facilities segment is predicted to witness the highest growth rate, due to the rising elderly population requiring consistent medication management. These facilities prioritize safety and accuracy in drug administration, which multi-dose packaging supports by reducing medication errors. Staff efficiency improves as pre-packaged doses save time and streamlines dispensing processes. The demand for compliance packaging grows as regulatory bodies emphasize adherence in care settings. Consequently, long-term care facilities drive sustained growth in the adoption of multi-dose packaging systems.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising geriatric population, increasing prevalence of chronic diseases, and expanding healthcare infrastructure. Countries like China, Japan, and India are investing in advanced pharmaceutical packaging technologies to enhance patient compliance and reduce medication errors. Growing awareness of smart medication management, along with rapid urbanization and digital health adoption, further fuels demand. Local players are actively innovating with cost-effective and sustainable packaging solutions to cater to the rising need in hospital and homecare settings.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by stringent regulatory standards, advanced pharmaceutical practices, and strong adoption of automation in drug dispensing. The U.S. and Canada are focusing on minimizing medication non-adherence through innovative blister packs and RFID-enabled packaging. The presence of key market players and growing demand from long-term care facilities, nursing homes, and outpatient services amplify market expansion. Integration with electronic health records (EHRs) and digital prescription platforms are gaining traction, making multi-dose packaging essential for operational efficiency and improved patient outcomes.
Key players in the market
Some of the key players profiled in the Multi-Dose Packaging System Market include Omnicell, Inc., Swisslog Healthcare, Tosho Co., Ltd., Manrex Limited, Becton, Dickinson and Company (BD), McKesson Corporation, Cardinal Health, Inc., Baxter International Inc., Parata Systems, LLC, ScriptPro LLC, Yuyama Co., Ltd., ARxIUM Inc., JVM Co., Ltd., Accu-Chart Plus Healthcare Systems, Inc. and Euclid Medical Products.
In May 2025, Tosho unveiled enhanced specifications for the Xana 4001U2 Advance, a high-capacity full-automatic tablet packing system. Updates included improved drug recognition accuracy, faster multi-dose dispensing, and streamlined user interface for hospital and pharmacy operations, boosting productivity while maintaining strict medication safety and traceability standards.
In May 2025, Omnicell launched a new line of RFID-enabled products called MedTrack. These are designed for perioperative and clinic settings, offering advanced automation, intelligent software workflows, and enhanced medication inventory management. The platform aims to reduce medication errors and streamline multi-dose packaging processes through automated tracking and inventory control.
In April 2025, Swisslog Healthcare's AutoPack(TM) upgrades with the U Canister and Variable Heater enhance packaging flexibility and efficiency. The U Canister holds up to 280 tablets, including irregular sizes, while the Variable Heater supports customizable package lengths (50-95 mm), streamlining cartfill and ADU workflows-crucial for addressing staff shortages and optimizing multi-dose medication delivery.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.